In the tumor, IL-33 distribution is heterogeneous among patients, observing both nuclear and cytoplasmic staining in tumor epithelial cells, with stromal staining in fibroblast-like cells, mononuclear cells, and endothelium (Figure 5B). This evidence concerns the gene IL33 and neoplasm.